Cita APA

Piedra, A., Martínez-Recio, S., Hernández, A., Morán, T., Arriola, E., Recuero-Borau, J., . . . Majem, M. (2024). First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: Real-world data from a Spanish multicenter study.

Citación estilo Chicago

Piedra, A., et al. First-line Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Real-world Data From a Spanish Multicenter Study. 2024.

Cita MLA

Piedra, A., et al. First-line Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Real-world Data From a Spanish Multicenter Study. 2024.